Comparison of epicardial and myocardial perfusions after primary coronary angioplasty for ST-elevation myocardial infarction in patients under and over 75 years of age

Background and aims: Patients aged ≥75 years compose a high-risk subgroup for acute myocardial infarction (AMI). It is unknown whether myocardial perfusion in these patients is decreased compared with younger ones after primary percutaneous coronary intervention (PPCI), which may contribute to their worse prognosis. We compared epicardial and myocardial perfusions as well as short-term outcomes between elderly and younger patients undergoing PPCI. Methods: A total of 547 consecutive PPCI patients were prospectively enrolled; of these, 106 were elderly (≥75 yrs). Epicardial perfusion was evaluated by the Thrombolysis in Myocardial Infarction (TIMI) flow grade and corrected TIMI frame count (CTFC), and myocardial perfusion was evaluated by the TIMI myocardial perfusion grade (TMPG) and ST-segment resolution (STR). Results: Despite comparable epicardial perfusion pre- and post-PPCI, elderly patients had impaired myocardial perfusion after PPCI, as measured by reduced TMPG (35.9% vs 14.5%, p=0.001) and absent STR (18.9% vs 9.8%, p=0.009). After adjusting for clinical and angiographic risk profiles, multivariate analysis showed that age ≥75 years remained independently associated with reduced TMPG or absent STR. In the whole population, multivariate analysis revealed that both age ≥75 years and absent STR were independently associated with 3-month major adverse cardiac events (MACE). In the elderly subgroup, multivariate analysis identified absent STR as the strongest determinant of 3-month MACE. Conclusions: Age is associated with impaired myocardial perfusion, but not epicardial perfusion, after PPCI for AMI. To further improve the outcome of elderly AMI patients, efforts should be aimed at improving myocardial perfusion beyond epicardial recanalization.

[1]  R. D'Agostino Propensity Scores in Cardiovascular Research , 2007, Circulation.

[2]  M. Flather,et al.  Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI). , 2004, American heart journal.

[3]  M. Sabatine,et al.  Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial. , 2005, American heart journal.

[4]  M. Movahed,et al.  Microvascular dysfunction following primary percutaneous coronary intervention in the setting of ST-elevation myocardial infarction. , 2008, The Journal of invasive cardiology.

[5]  Meng Xu,et al.  Propensity matched comparison of outcomes in older and younger patients after coronary artery bypass graft surgery. , 2008, The Annals of thoracic surgery.

[6]  M. Naylor,et al.  Acute Coronary Care in the Elderly, Part II: ST-Segment–Elevation Myocardial Infarction A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology , 2007, Circulation.

[7]  D. Sane,et al.  Aging and Thrombosis , 2002, Seminars in thrombosis and hemostasis.

[8]  Yuan Zhang,et al.  Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. , 1998, Circulation.

[9]  Song Ding,et al.  TIMI myocardial perfusion frame count: A new method to assess myocardial perfusion and its predictive value for short‐term prognosis , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  S. Sdringola,et al.  The dilemma of success: Percutaneous coronary interventions in patients ≥ 75 years of age—successful but associated with higher vascular complications and cardiac mortality , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[11]  J. Avorn,et al.  The exclusion of the elderly and women from clinical trials in acute myocardial infarction. , 1992, JAMA.

[12]  F. Eberli,et al.  Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST‐elevation myocardial infarction , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  M. Cohen,et al.  Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. , 1985, Journal of the American College of Cardiology.

[14]  K. Wegscheider,et al.  Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. , 1994, Journal of the American College of Cardiology.

[15]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[16]  M. Rich Treatment of acute myocardial infarction. , 2001, The American journal of geriatric cardiology.

[17]  P. Armstrong,et al.  Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. , 2008, European heart journal.

[18]  L. Klein Optimal revascularization strategies for ST-segment elevation myocardial infarction in the elderly patient. , 2007, The American journal of geriatric cardiology.

[19]  F. Cosentino,et al.  Aging and endothelial dysfunction. , 2007, Clinical hemorheology and microcirculation.

[20]  C M Gibson,et al.  Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.

[21]  Á. Avezum,et al.  Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction , 2004 .

[22]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[23]  M. Naylor,et al.  Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.

[24]  B. Gersh,et al.  Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. , 2004, American heart journal.

[25]  H. Suryapranata,et al.  The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. , 2001, Journal of the American College of Cardiology.

[26]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.